As of late November 2025, the US, UK, Canada, and Japan face an early, severe flu season driven by the H3N2 subclade K variant, which has mutated beyond current vaccine strains. Hospital admissions and flu cases, especially among children and vulnerable groups, are rising. Concurrently, norovirus infections are doubling nationwide, with health officials urging hygiene and vaccination to mitigate risks.